Data gathered: December 21
AI Stock Analysis - Johnson & Johnson (JNJ)
Analysis generated November 29, 2024. Powered by Chat GPT.
Johnson & Johnson (JNJ) is a multinational corporation founded in 1886. It is engaged in the research, development, manufacturing, and sale of a broad range of healthcare products. The company operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. Headquartered in New Brunswick, New Jersey, J&J is a prominent leader in the healthcare industry, known for its innovative medicines, medical devices, and consumer products.
Stock Alerts - Johnson & Johnson (JNJ)
 |
Johnson & Johnson | December 17 Over the past few months, there has been an downward trend in the business outlook. |
|
Johnson & Johnson | December 13 Insider Alert: WEINBERGER MARK A is buying shares |
|
Johnson & Johnson | December 13 Reddit mentions are up by 1008% in the last 24h. |
|
Johnson & Johnson | December 9 Jared Moskowitz (member of U.S. congress) is buying shares |
Alternative Data for Johnson & Johnson
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
| Price | $144.47 |
| Target Price | Sign up |
| Volume | 15,040,000 |
| Market Cap | $346B |
| Year Range | $141.06 - $166.05 |
| Dividend Yield | 3.43% |
| PE Ratio | 23.73 |
| Analyst Rating | 33% buy |
| Earnings Date | January 22 '25 |
| Industry | Drug Manufacturers |
In the news
Is Johnson & Johnson (JNJ) a Cheap NYSE Stock to Invest in Now?December 20 - Yahoo Entertainment |
|
Class action filed against Johnson & Johnson over 'ineffective' flu medicationDecember 20 - ABC News (AU) |
|
Johnson & Johnson stock underperforms Thursday when compared to competitorsDecember 19 - MarketWatch |
|
 |
Why Is Johnson & Johnson (JNJ) Among the Best Dividend Stocks to Invest In?December 18 - Yahoo |
 |
Johnson & Johnson: Dividend Legend At A DiscountDecember 18 - SeekingAlpha |
|
Jim Cramer on Johnson & Johnson (JNJ): How the Pharma Giant is Handling Billion-Dollar Lawsuits and Legal BattlesDecember 18 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 22.5B | 13.7B | 15.5B | 2.69B | 5.04B | 2.420 |
| Q2 '24 | 22.4B | 13.6B | 15.6B | 4.69B | 6.47B | 2.820 |
| Q1 '24 | 21.2B | 13.2B | 14.9B | 3.26B | 4.97B | 2.710 |
| Q4 '23 | 21.4B | 14.1B | 14.6B | 4.05B | 5.99B | 2.290 |
| Q3 '23 | 21.2B | 13.3B | 14.7B | 26B | 28.2B | 2.660 |
Insider Transactions View All
| WEINBERGER MARK A filed to buy 1,000 shares at $147.2. December 12 '24 |
| Decker Robert J filed to sell 18,973 shares at $165.1. September 3 '24 |
| Broadhurst Vanessa filed to sell 15,043 shares at $162.2. March 13 '24 |
| Taubert Jennifer L filed to sell 141,416 shares at $156.3. February 12 '24 |
| Hait William filed to sell 87,747 shares at $172. July 27 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Eli Lilly and CompanyLLY |
$767.76 0% | 61 |
 |
PfizerPFE |
$26.36 0% | 37 |
 |
AstrazenecaAZN |
$65.35 0% | 54 |
 |
AbbVieABBV |
$175.58 0% | 60 |
 |
TherapeuticsMDTXMD |
$1.11 0% | 41 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Jared Moskowitz |
Dec 9, 24 | Buy | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
| Josh Gottheimer |
Dec 6, 24 | Buy | $1K - $15K |
Read more about Johnson & Johnson (JNJ) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Johnson & Johnson?
The Market Cap of Johnson & Johnson is $346B.
What is Johnson & Johnson's PE Ratio?
As of today, Johnson & Johnson's PE (Price to Earnings) ratio is 23.73.
When does Johnson & Johnson report earnings?
Johnson & Johnson will report its next earnings on January 22 '25.
What is the current stock price of Johnson & Johnson?
Currently, the price of one share of Johnson & Johnson stock is $144.47.
How can I analyze the JNJ stock price chart for investment decisions?
The JNJ stock price chart above provides a comprehensive visual representation of Johnson & Johnson's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Johnson & Johnson shares. Our platform offers an up-to-date JNJ stock price chart, along with technical data analysis and alternative data insights.
Does JNJ offer dividends to its shareholders?
Yes, Johnson & Johnson (JNJ) offers dividends to its shareholders, with a dividend yield of 3.43%. This dividend yield represents Johnson & Johnson's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Johnson & Johnson in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Johnson & Johnson?
Some of the similar stocks of Johnson & Johnson are Eli Lilly and Company, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.
.